Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04413071Completed

Cardiac COVID-19 Health Care Workers

Role: lead

NCT03981588Unknown

Cardiotoxicity in the Elderly

Role: lead

NCT03429452Completed

The SALMANTICOR Study

Role: lead

NCT03435133Not ApplicableCompleted

Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI

Role: lead

NCT00404287Phase 4Terminated

Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.

Role: lead

All 5 trials loaded